Evidence map›Paper›PMID 40898271›Full record

ArticlePerioperative medicine (London, England)2025

Effective doses of alfentanil combined with propofol for gastroscopy in patients of different ages under Narcotrend monitoring: a prospective dose-finding study utilizing the up-and-down sequential allocation method.

Lili Jiang, Zhe Peng, Yuhui Deng, Zebang Qin, Jianxia Li, Jinping Huang, Zaisheng Qin

Abstract read
In one paragraph

Article in Perioperative medicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lili Jiang *Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhe Peng *Foshan Maternity and Children's Hospital, Foshan, China.
Yuhui DengThe Seventh Affiliated Hospital of Southern Medical University, Foshan, China.
Zebang QinThe Seventh Affiliated Hospital of Southern Medical University, Foshan, China.
Jianxia LiThe Seventh Affiliated Hospital of Southern Medical University, Foshan, China.
Jinping HuangThe Seventh Affiliated Hospital of Southern Medical University, Foshan, China. huangjpsmu@163.com.
Zaisheng QinNanfang Hospital, Southern Medical University, Guangzhou, China. zsqinsmu@163.com.

Funding

Foshan Medical Research Project 20230250
6 · The paper itself

Abstract

backgroundPainless gastroscopy is preferred by both patients and physicians, as it minimizes discomfort during the procedure. Alfentanil, a short-acting opioid analgesic, possesses pharmacological properties that make it suitable for inducing analgesia during gastroscopy. However, research on the optimal dosage of alfentanil when used in combination with propofol for gastroscopy is limited. Therefore, this study aimed to investigate the 50% and 95% effective doses (ED50 and ED95, respectively) of alfentanil in combination with propofol for gastroscopy, using Narcotrend monitoring.

methodsElective gastroscopy was performed in 51 patients aged 18-80 years, with a body mass index of 18-28 kg/m

resultsUnder the sedation conditions induced using alfentanil and propofol and detected using Narcotrend, the ED50 (95% CI) were 5.39 µg/kg (4.76-6.47) in the youth group and 5.69 µg/kg (4.67-6.31) in the elderly group, respectively.

conclusionsThe ED50 of alfentanil combined with propofol for gastroscopy under Narcotrend monitoring were 5.39 µg/kg in the youth group and 5.69 µg/kg in the elderly group, respectively.

Indexed as

AlfentanilGastroscopyMedian effective doseNarcotrendPropofol

Identifiers

PMID40898271
PMCPMC12406509

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.